Rare-disease genetics in the era of next-generation sequencing: discovery to translation

[1]  Michael Brudno,et al.  PhenoTips: Patient Phenotyping Software for Clinical and Research Use , 2013, Human mutation.

[2]  Nicholas Katsanis,et al.  Molecular genetic testing and the future of clinical genomics , 2013, Nature Reviews Genetics.

[3]  Tudor Groza,et al.  Getting Ready for the Human Phenome Project: The 2012 Forum of the Human Variome Project , 2013, Human mutation.

[4]  R. Reading,et al.  Diagnostic exome sequencing in persons with severe intellectual disability , 2013 .

[5]  J. Rilstone,et al.  Brain dopamine-serotonin vesicular transport disease and its treatment. , 2013, The New England journal of medicine.

[6]  D. Valle,et al.  PhenoDB: A New Web-Based Tool for the Collection, Storage, and Analysis of Phenotypic Features , 2013, Human mutation.

[7]  Christine Van Broeckhoven,et al.  Genetic insights in Alzheimer's disease , 2013, The Lancet Neurology.

[8]  A. V. Vulto-van Silfhout,et al.  Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia. , 2012, American journal of human genetics.

[9]  S. Ferdinandusse,et al.  Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency , 2012, Orphanet Journal of Rare Diseases.

[10]  S. Scherer,et al.  Adult siblings with homozygous G6PC3 mutations expand our understanding of the severe congenital neutropenia type 4 (SCN4) phenotype , 2012, BMC Medical Genetics.

[11]  S. Mundlos,et al.  Whole exome sequencing identified a novel zinc-finger gene ZNF141 associated with autosomal recessive postaxial polydactyly type A , 2012, Journal of Medical Genetics.

[12]  De Silva,et al.  Sri Lankan population change and demographic bonus challenges and opportunities in the new millennium , 2012 .

[13]  H. Waterham,et al.  The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives , 2012, Orphanet Journal of Rare Diseases.

[14]  Shamil R Sunyaev,et al.  Inferring causality and functional significance of human coding DNA variants. , 2012, Human molecular genetics.

[15]  P. Ascierto.  MEK inhibition in BRAF-mutated melanoma. , 2012, The New England journal of medicine.

[16]  K. Boycott,et al.  MEK inhibition in BRAF-mutated melanoma. , 2012, The New England journal of medicine.

[17]  T. Ohashi.  Enzyme replacement therapy for lysosomal storage diseases. , 2012, Pediatric endocrinology reviews : PER.

[18]  Janel O. Johnson,et al.  Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. , 2012, Brain : a journal of neurology.

[19]  N. Das,et al.  RNAi-based therapies for Huntington's disease: delivery challenges and opportunities. , 2012, Therapeutic delivery.

[20]  Bruce M. Wentworth,et al.  Targeting nuclear RNA for in vivo correction of myotonic dystrophy , 2012, Nature.

[21]  S. Gabriel,et al.  De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly , 2012, Nature Genetics.

[22]  J. Veltman,et al.  De novo mutations in human genetic disease , 2012, Nature Reviews Genetics.

[23]  E. Lander,et al.  Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. , 2012, The Journal of clinical investigation.

[24]  Sean Ekins,et al.  A generalizable pre-clinical research approach for orphan disease therapy , 2012, Orphanet Journal of Rare Diseases.

[25]  J. Shendure,et al.  De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes , 2012, Nature Genetics.

[26]  S. C. Chafe,et al.  Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis , 2012, Nature.

[27]  J. D. Lartigue.  Tafamidis for transthyretin amyloidosis. , 2012 .

[28]  E. Thorland,et al.  Towards an evidence‐based process for the clinical interpretation of copy number variation , 2012, Clinical genetics.

[29]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[30]  S. Levy,et al.  Familial diarrhea syndrome caused by an activating GUCY2C mutation. , 2012, The New England journal of medicine.

[31]  Y. S. Kim,et al.  Global Prevalence of Autism and Other Pervasive Developmental Disorders , 2012, Autism research : official journal of the International Society for Autism Research.

[32]  D. Labuda,et al.  Mutations in C5ORF42 cause Joubert syndrome in the French Canadian population. , 2012, American journal of human genetics.

[33]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[34]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[35]  Tadashi Kaname,et al.  New from NPG , 2012, Nature Medicine.

[36]  Robert C. Green,et al.  Exploring concordance and discordance for return of incidental findings from clinical sequencing , 2012, Genetics in Medicine.

[37]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[38]  Gabriele Gillessen-Kaesbach,et al.  Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. , 2012, American journal of human genetics.

[39]  A. Thrasher,et al.  Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency. , 2012, Current gene therapy.

[40]  Steven J. M. Jones,et al.  Mutations in EZH2 cause Weaver syndrome. , 2012, American journal of human genetics.

[41]  Carol J. Bult,et al.  Mouse Phenome Database (MPD) , 2011, Nucleic Acids Res..

[42]  Helen Diller Family.  Targeting the TGFβ signalling pathway in disease , 2012 .

[43]  J. Dungan,et al.  Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing , 2012 .

[44]  Y. Eto,et al.  Proteasome inhibitors improve the function of mutant lysosomal α-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutation. , 2011, Biochemical and biophysical research communications.

[45]  Matthias Griese,et al.  A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. , 2011, The New England journal of medicine.

[46]  M. Leyne,et al.  Kinetin Improves IKBKAP mRNA Splicing in Patients With Familial Dysautonomia , 2011, Pediatric Research.

[47]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[48]  Kym M Boycott,et al.  Mutations in NOTCH2 in families with Hajdu‐Cheney syndrome , 2011, Human mutation.

[49]  Darin P Clark,et al.  Whole-animal imaging, gene function, and the Zebrafish Phenome Project. , 2011, Current opinion in genetics & development.

[50]  J. Shendure,et al.  Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data , 2011, Nature Reviews Genetics.

[51]  Jamie K Teer,et al.  A mosaic activating mutation in AKT1 associated with the Proteus syndrome. , 2011, The New England journal of medicine.

[52]  A. MacKenzie,et al.  Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway. , 2011, The Journal of clinical investigation.

[53]  S. Kingsmore,et al.  Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Become Routine? , 2011, Science Translational Medicine.

[54]  Muin J Khoury,et al.  Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time , 2011, Genetics in Medicine.

[55]  S. Robertson,et al.  Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss , 2011, Nature Genetics.

[56]  Pierre Lindenbaum,et al.  Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis , 2011, Nature Genetics.

[57]  B. Neel,et al.  MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. , 2011, The Journal of clinical investigation.

[58]  Shin'ichi Takeda,et al.  [Exon-skipping therapy for Duchenne muscular dystrophy]. , 2011, Rinsho shinkeigaku = Clinical neurology.

[59]  J. Goldblatt,et al.  The Impact of Single Gene and Chromosomal Disorders on Hospital Admissions of Children and Adolescents: A Population-Based Study , 2010, Public Health Genomics.

[60]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[61]  M. Samuels.  Saturation of the Human Phenome , 2010, Current genomics.

[62]  Janel O. Johnson,et al.  Exome sequencing in Brown-Vialetto-van Laere syndrome. , 2010, American journal of human genetics.

[63]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[64]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[65]  J. Mendell,et al.  Gentamicin‐induced readthrough of stop codons in duchenne muscular dystrophy , 2010, Annals of neurology.

[66]  Christian Gilissen,et al.  De novo mutations of SETBP1 cause Schinzel-Giedion syndrome , 2010, Nature Genetics.

[67]  P. Stenson,et al.  Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics , 2010, Human mutation.

[68]  Y. Crow,et al.  Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. , 2010, American journal of human genetics.

[69]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[70]  J. Kurtzberg,et al.  Transplant outcomes in mucopolysaccharidoses. , 2010, Seminars in hematology.

[71]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[72]  Faraz Farooq,et al.  p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR. , 2009, Human molecular genetics.

[73]  Satoshi Nakanishi,et al.  National BioResource Project-Rat and related activities. , 2009, Experimental animals.

[74]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[75]  P. Robinson,et al.  The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. , 2008, American journal of human genetics.

[76]  V. McKusick.  Mendelian Inheritance in Man and Its Online Version, OMIM , 2007, The American Journal of Human Genetics.

[77]  I. Krantz,et al.  NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. , 2006, American journal of human genetics.

[78]  Tadao Serikawa,et al.  Rat Phenome Project: the untapped potential of existing rat strains. , 2005, Journal of applied physiology.

[79]  S. McCandless,et al.  The burden of genetic disease on inpatient care in a children's hospital. , 2004, American journal of human genetics.

[80]  C. Sabatti,et al.  The Human Phenome Project , 2003, Nature Genetics.

[81]  H. Leonard,et al.  The epidemiology of mental retardation: challenges and opportunities in the new millennium. , 2002, Mental retardation and developmental disabilities research reviews.

[82]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[83]  S. Aymé,et al.  Information sur les maladies rares : le projet Orphanet , 1998 .

[84]  S Aymé,et al.  [Information on rare diseases: the Orphanet project]. , 1998, La Revue de medecine interne.

[85]  M J Khoury,et al.  Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study. , 1997, Archives of pediatrics & adolescent medicine.

[86]  N. M. Lewis,et al.  Accelerating research and development of innovative technologies , 1995 .

[87]  H B Newcombe,et al.  Genetic disorders in children and young adults: a population study. , 1988, American journal of human genetics.

[88]  C. Carter.  Monogenic disorders. , 1977, Journal of medical genetics.